Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, RXO Inc’s stock clocked out at $17.15, up 2.57% from its previous closing price of $16.72. In other words, the price has increased by $2.57 from its previous closing price. On the day, 2.09 million shares were traded. RXO stock price reached its highest trading level at $17.26 during the session, while it also had its lowest trading level at $16.605.
Ratios:
To gain a deeper understanding of RXO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.37.
On March 13, 2025, Truist started tracking the stock assigning a Buy rating and target price of $24. On March 07, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $19.Deutsche Bank initiated its Hold rating on March 07, 2025, with a $19 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 14 ’25 when Szlosek Thomas A bought 7,500 shares for $16.65 per share. The transaction valued at 124,875 led to the insider holds 16,200 shares of the business.
Szlosek Thomas A bought 8,700 shares of RXO for $125,354 on May 09 ’25. The Director now owns 8,700 shares after completing the transaction at $14.41 per share. On Nov 12 ’24, another insider, Nettles Michelle, who serves as the Director of the company, bought 1,800 shares for $27.89 each. As a result, the insider paid 50,202 and bolstered with 15,185 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2812377088 and an Enterprise Value of 3473381120. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.51 while its Price-to-Book (P/B) ratio in mrq is 1.77. Its current Enterprise Value per Revenue stands at 0.625 whereas that against EBITDA is 25.353.
Stock Price History:
The Beta on a monthly basis for RXO is 1.55, which has changed by -0.33268481 over the last 52 weeks, in comparison to a change of 0.17089343 over the same period for the S&P500. Over the past 52 weeks, RXO has reached a high of $31.98, while it has fallen to a 52-week low of $12.19. The 50-Day Moving Average of the stock is 6.50%, while the 200-Day Moving Average is calculated to be -10.01%.
Shares Statistics:
It appears that RXO traded 1.88M shares on average per day over the past three months and 1908620 shares per day over the past ten days. A total of 163.97M shares are outstanding, with a floating share count of 160.61M. Insiders hold about 2.06% of the company’s shares, while institutions hold 105.81% stake in the company. Shares short for RXO as of 1756425600 were 7917682 with a Short Ratio of 4.22, compared to 1753920000 on 6810179. Therefore, it implies a Short% of Shares Outstanding of 7917682 and a Short% of Float of 13.5.
Earnings Estimates
The market rating for RXO Inc (RXO) is a result of the insights provided by 18.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.08, with high estimates of $0.1 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.17 and $0.13 for the fiscal current year, implying an average EPS of $0.15. EPS for the following year is $0.41, with 19.0 analysts recommending between $0.67 and $0.28.
Revenue Estimates
In the current quarter, 15 analysts expect revenue to total $1.45B. It ranges from a high estimate of $1.52B to a low estimate of $1.4B. As of the current estimate, RXO Inc’s year-ago sales were $1.04BFor the next quarter, 15 analysts are estimating revenue of $1.6B. There is a high estimate of $1.69B for the next quarter, whereas the lowest estimate is $1.49B.
A total of 18 analysts have provided revenue estimates for RXO’s current fiscal year. The highest revenue estimate was $6.06B, while the lowest revenue estimate was $5.73B, resulting in an average revenue estimate of $5.91B. In the same quarter a year ago, actual revenue was $4.55BBased on 18 analysts’ estimates, the company’s revenue will be $6.29B in the next fiscal year. The high estimate is $6.73B and the low estimate is $5.95B.
